ANTIMICROBIAL RESISTANCE IN SEXUALLY TRANSMITTED INFECTIONS

Sexually Transmitted Infections (STIs), including gonorrhea, are an actual problem that continues to bother doctors and health care providers. After all, the consequences of urogenital infections are harm to the sexual and reproductive health of the population, to future generations. The level of registration of individual STIs continues to increase, which puts before the health care system and society as a whole the urgent task of preventing the harmful effects of this pathology on public health. In recent years, according to research, the epidemiological characteristics of STIs have changed dramatically. These changes are associated with the expansion of the age and social composition of STI patients. There are changes in the etiology of STIs and the antimicrobial resistance of their pathogens. There are new mechanisms of resistance of STI agents in the most important antibiotics and chemotherapeutic drugs. There is every reason to believe that the problem of antibiotic-resistant strains will continue to exist, which hampers the effectiveness of treatment regimens. Efforts at many levels are important to effectively address this problem, particularly in the areas of new drug development, alternative treatment regimens, and further research on testing antimicrobial resistance.